To reveal the clinical significance of these 2 lncRNAs in LUAD, genetic alterations, as well as alterations to other clinical features, such as sex, age in diagnosis, tumor stage, metastatic status, lymph node metastasis and KRAS mutation, were investigated. The gene discussed is KRAS; the disease is neoplasm.